Announcements
- OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
- OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
- OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
- OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024
- OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual International Children’s Spine Symposium (ICSS)
- OrthoPediatrics Corp. to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
- OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis
- OrthoPediatrics Corp. Named One of the 2024 Best Places to Work in Indiana
- OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
More ▼
Key statistics
As of last trade, OrthoPediatrics Corp (2X7:FRA) traded at 31.00, 40.91% above the 52 week low of 22.00 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 31.00 |
---|---|
High | 31.00 |
Low | 31.00 |
Bid | 31.20 |
Offer | 31.40 |
Previous close | 29.80 |
Average volume | 30.89 |
---|---|
Shares outstanding | 23.83m |
Free float | 16.24m |
P/E (TTM) | -- |
Market cap | 806.13m USD |
EPS (TTM) | -0.9647 USD |
Data delayed at least 15 minutes, as of May 29 2024 07:00 BST.
More ▼